Advanced search: Search from
Select basic information for advanced search
| Free word |
|---|
Rchr
J-GLOBAL ID：200901057528300901
Update date: Aug. 27, 2024 Iha Hidekatsu
イハ ヒデカツ | Iha Hidekatsu
Oita University Faculty of Medicine
About Oita University Faculty of Medicine
Research field (6)：
Molecular biology
, Immunology
, Tumor biology
, Virology
, Laboratory animal science
, Experimental pathology
Research theme for competitive and other funds (13)： - 2021 - 2024 発症危険度を峻別する新規ATLバイオマーカーの同定と臨床検体における評価
- 2017 - 2021 ATLL及びB細胞性リンパ腫発症リスク評価・判定法の開発
- 2017 - 2019 Molecular and sero-epidemiologcal survey on the prevalence of human T-lymphotropic virus type 1 (HTLV-1), a causative agent of adult T-cell leukemia / lymphoma, in Sabah, Malaysia
- 2015 - 2018 Identification of ATLL-associated genes in Rapid ATLL model mouse
- 2016 - 2018 レクチンマイクロアレイを用いた食道癌の再発予測マーカーの開発
Show all
- Yu Wang, Jiazhou Li, Shingo Nakahata, Hidekatsu Iha. Complex Role of Regulatory T Cells (Tregs) in the Tumor Microenvironment: Their Molecular Mechanisms and Bidirectional Effects on Cancer Progression. International journal of molecular sciences. 2024. 25. 13
- Yu Wang, Yoshiyuki Tsukamoto, Mitsuo Hori, Hidekatsu Iha. Disulfidptosis: A Novel Prognostic Criterion and Potential Treatment Strategy for Diffuse Large B-Cell Lymphoma (DLBCL). International journal of molecular sciences. 2024. 25. 13
- Hidekatsu Iha. HTLV-1: Neglected Virus in Southeast Asia for Decades. Borneo Journal of Medical Sciences (BJMS). 2024. 18. 2
- Haruka Sudo, Yasuhiro Tonoyama, Emi Ikebe, Hiroo Hasegawa, Hidekatsu Iha, Yo-Ichi Ishida. Proteomic analysis of adult T-cell leukemia/lymphoma: A biomarker identification strategy based on preparation and in-solution digestion methods of total proteins. Leukemia research. 2024. 138. 107454-107454
- Tomonaga Ichikawa, Akira Suekane, Shingo Nakahata, Hidekatsu Iha, Kazuya Shimoda, Takashi Murakami, Kazuhiro Morishita. Inhibition of PRMT5/MEP50 Arginine Methyltransferase Activity Causes Cancer Vulnerability in NDRG2low Adult T-Cell Leukemia/Lymphoma. International journal of molecular sciences. 2024. 25. 5
- WANG Yu, OKITA Mizuho, OGATA Masao, HAGIWARA Shotaro, YASUI Hiroshi, UCHIMARU Kaoru, KOH Kiryan, UTSUNOMIYA Atae, WATANABE Toshiki, WATANABE Toshiki, et al. Identification and validation of the novel ATL biomarkers. 日本HTLV-1学会学術集会. 2023. 9th
- 池辺詠美, 池辺詠美, 松岡佐保子, 中島誠, 村岡弘美, 吉村千穂子, 山岸誠, 内丸薫, 伊波英克, 内丸薫, et al. Investigation of the usefulness of NAE inhibitors as novel ATL therapies. 日本HTLV-1学会学術集会. 2023. 9th
- IHA Hidekatsu, IHA Hidekatsu, SABRI Shanaz Irwani Binti, KUGAN Omar Kwang, SHAHAROM Saliz Mazrina Binti, JEFFREE Mohammad Saffree, FORNACE Kimberly, MORI Daisuke, YAHIRO Takaaki, HAMAGUCHI Isao, et al. Serological survey for HTLV-1 infection in the Sabah state of Northern Borneo, Malaysia. 日本HTLV-1学会学術集会. 2023. 9th
- 高橋 美咲, 津山 尚宏, 伊波 英克, 坂井 晃. IMiDs耐性骨髄腫細胞株によるトランスクリプトーム/プロテオーム解析を用いた新規治療標的分子探索. 日本血液学会学術集会. 2022. 84回. 1173-1173
- 伊波 英克, 王 宇, 下崎 俊介, 池辺 詠美, 山本 淳一, ファイフ・ニコール, 市川 朝永, 堀 光雄, 緒方 正男, 塚本 善之, et al. IMiDs/CELMoDによるATL細胞の増殖抑制とその機序. 日本血液学会学術集会. 2022. 84回. 1215-1215
- 非ホジキンリンパ腫発症のリスク判定補助方法
- Methods for determining drug efficacy for treatment of cancers using ratios of cereblon associated proteins.
- Methods for determining;drug efficacy for;treatment of cancer using;ratios of cereblon;associated proteins
- 成人T細胞白血病/リンパ腫の発症抑制剤の有効成分をスクリーニングする方法
- 糖質プロファイリングによる血液腫瘍診断方法
- T-Cell Leukemia - Characteristics, Treatment and Prevention
INTECH 2013 - HTLV-1と疾患
文光堂 2007
- 2023/07 - 現在 Frontiers in Microbiology (Virology) Associate Editor
- 2014/08 - 現在 日本HTLV-1学会 評議員
- 2008/04 - 2012/07 大分TLO 理事
- 2003 - NIH recognized employee award
- 2002 - NIH recognized employee award
American Society for Microbiology
, THE JAPANESE ASSOCIATION FOR MOLECULAR TARGET THERAPY OF CANCER
, THE JAPANESE CANCER ASSOCIATION
, THE MOLECULAR BIOLOGY SOCIETY OF JAPAN
, 日本HTLV-1学会
, JAPANESE SOCIETY FOR IMMUNOLOGY (JSI)
, THE JAPANESE SOCIETY FOR VIROLOGY
, THE JAPANESE SOCIETY FOR COMPLEMENTARY AND ALTERNATIVE MEDICINE
, THE SOCIETY FOR BIOTECHNOLOGY, JAPAN
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.
Return to Previous Page
